TICKERNERD
Menu
ARDTARDTHealthcare · Medical Care Facilities

ARDT Stock Forecast: Ardent Health, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$12
+2.22% on the day

The 13 Wall Street analysts covering Ardent Health, Inc. hold a median 12-month price target of $13 — +8.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 58 of 100 as at 14 Oct 2026 — in the upper half.

Market cap
$1.6B
Ticker Nerd rank
58 / 100
Median analyst target
$13
Analysts covering
13
Revenue$1.6B−1.4% y/y
Operating income$55.8M
Net income$34.7M
Free cash flow$158.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+9.8%
1M
+8.6%
YTD
+35.3%
1Y
−16.4%
From 52W high
−21.4%
From 52W low
+52.6%
$8
$15
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ARDT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ardent Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
58 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
93
Accruals
78
Issuance
77
Revisions
53
Quality
46
Momentum
43
Size
37
Volatility
32
Growth
27

Value (93): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Growth (27): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ARDT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ARDT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$8$10$12$14$16Jan 26Apr 26Jul 26Oct 26ARDTHigh $14Median $13Low $11

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says13 analysts
7 Buy5 Hold1 Sell
Low $11Median $13High $14

The green dot is the last close — the median target sits +8.8% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 2 moved it down.

DateFirmActionRatingTarget
23 Sept 2026BMO CapitalInitiatesMarket Perform$11
18 Sept 2026Leerink PartnersMaintainsOutperform$14
10 Aug 2026RBC CapitalMaintainsOutperform—
10 Aug 2026RBC CapitalMaintainsOutperform$12 → $13
6 Aug 2026GuggenheimMaintainsBuy$13 → $14
6 Aug 2026GuggenheimMaintainsBuy—
6 Aug 2026Truist SecuritiesMaintainsBuy$12 → $13
6 Aug 2026Truist SecuritiesMaintainsBuy—
14 July 2026Truist SecuritiesMaintainsBuy$13 → $12
14 July 2026Truist SecuritiesMaintainsBuy—
9 July 2026RBC CapitalMaintainsOutperform$13 → $12
9 July 2026RBC CapitalMaintainsOutperform—
7 May 2026UBSMaintainsBuy—
10 Mar 2026RBC CapitalMaintainsOutperform—
6 Mar 2026Leerink PartnersMaintainsOutperform—
20 Jan 2026JP MorganMaintainsNeutral—
18 Dec 2025MizuhoMaintainsOutperform—
18 Dec 2025UBSMaintainsBuy—
24 Nov 2025JP MorganMaintainsNeutral—
18 Nov 2025GuggenheimMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ARDT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ARDT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Ardent Health, Inc. returned −16.4% against +17.5% for the S&P 500, dividends included.

ARDT vs S&P 500, last 12 monthsTotal return, rebased to 100
60708090100110120Jan 26Apr 26Jul 26Oct 26ARDTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ARDT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−13.2%
Analysts raising
0
Analysts cutting
2
Fundamentals

Ardent Health, Inc. (ARDT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
22.1×

Cheaper than 34% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
1.3×

Cheaper than 62% of US stocks

EV / EBITDA
8.5×

Cheaper than 43% of US stocks

Growth & margins
Revenue growth (YoY)
−1.4%

Higher than 25% of US stocks

Earnings growth (YoY)
−76.8%

Higher than 5% of US stocks

Gross margin
41.1%

Higher than 51% of US stocks

Operating margin
3.4%

Higher than 51% of US stocks

Net margin
1.2%

Higher than 50% of US stocks

Returns & dividend
Return on equity
10.0%

Higher than 63% of US stocks

Return on assets
3.1%

Higher than 66% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Ardent Health, Inc. (ARDT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Ardent Health, Inc. has a market value of $1.6B and an enterprise value of $3.6B.

  • Revenue in the twelve months to 30 June 2026: $6.4B. The latest quarter shrank 1.4% year on year.

  • Net income over the same four quarters: $168.6M, a 2.6% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $304.8M.

  • Shares outstanding: 141.9M.

  • Trailing P/E: 22.1×; forward P/E: 9.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Ardent Health, Inc. employs 19,500 people — $329K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

ARDT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
ARDTArdent Health, Inc.$1.6B
58
SNDASonida Senior Living, Inc.$1.7B
27
ASTHAstrana Health, Inc.$1.9B
69
SGRYSurgery Partners, Inc.$1.9B
43
HCSGHealthcare Services Group, Inc.$1.5B
95
AMNAMN Healthcare Services, Inc.$1.5B
100
AGLAgilon Health, Inc.$1.5B
70

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ardent Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ARDT news & analysis

Ardent Health Passed Its Health Check

Seeking Alpha · 3 Oct 2026positive

Seeking Alpha reiterated a bullish view on Ardent Health, calling shares deeply undervalued despite recent profitability declines. Revenue continues to grow with management projecting $6.4–$6.7 billion for the year, while EBITDA and cash flow are expected to fall short of prior results. Professional fees pressured margins, but management expects this cost trend to moderate in the second half, signaling potential stabilization.

Why it matters — ARDT watchers would care because the piece highlights continued revenue growth and expectations of margin stabilization, even as profitability measures lag earlier results.

Is the Options Market Predicting a Spike in Ardent Health Stock?

Zacks Investment Research · 16 Sept 2026neutral

Zacks Investment Research reports that investors should pay close attention to Ardent Health (ARDT) stock based on recent movements in the options market. The article highlights notable options activity as a signal of potential movement in the stock.

Why it matters — ARDT watchers would care because unusual options-market activity can serve as an early indicator of significant stock movement ahead.

Ardent Health Hospitals Earn Recognition in U.S. News & World Report's 2026-2027 Best Hospitals Rankings

Business Wire · 15 Sept 2026positive

Ardent Health announced that 13 hospitals across its network received recognition in U.S. News & World Report's 2026-2027 Best Hospitals rankings, including a Best Regional Hospital designation, regional specialty rankings, and 34 High Performing ratings across procedures and conditions.

Why it matters — For ARDT watchers, hospital quality recognition across 13 facilities reflects the network's clinical reputation and could support its standing in the competitive healthcare markets it serves.

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

Business Wire · 2 Sept 2026positive

Ardent Health has marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler, the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, and orthopedic services.

Why it matters — This expansion of specialty care services in a new combined patient-care and training facility represents growth of Ardent Health's East Texas operations and physician pipeline.

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Business Wire · 27 Aug 2026neutral

Ardent Health announced it will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, in Boston, Massachusetts. Members of the management team will take part in a fireside chat at 11 a.m. ET, with a live audio webcast available in the Investor Relations section of its website.

Why it matters — ARDT watchers would care because the company's management will be discussing the business in a public forum, offering an opportunity to hear directly from leadership at a major industry conference.

FAQ

Frequently asked questions about ARDT stock

What is the ARDT stock price forecast for 2026-2027?

The 13 Wall Street analysts covering Ardent Health, Inc. have a median 12-month price target of $13, with estimates ranging from $11 to $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ARDT stock a buy right now?

Of the 13 analysts covering Ardent Health, Inc., 7 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Ardent Health, Inc. 58 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ARDT?

As at 14 Oct 2026, Ardent Health, Inc. ranks 58 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (93 of 100).

Will ARDT stock go up?

No one can know that. What the data says: the median 12-month target from 13 analysts implies +8.8% from the last close, and Ticker Nerd's factor model ranks Ardent Health, Inc. 58 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ARDT stock forecast for 2030?

No analyst covering Ardent Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ARDT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $14 over the next 12 months.

How has ARDT stock performed over the past year?

Ardent Health, Inc. returned -16.4% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ardent Health, Inc. do?

Ardent Health, Inc. is a healthcare services company that owns and operates a network of hospitals, clinics, and other care facilities across the United States.

What is the latest news on ARDT?

The most recent item we track (Seeking Alpha, 3 Oct 2026): "Ardent Health Passed Its Health Check". Seeking Alpha reiterated a bullish view on Ardent Health, calling shares deeply undervalued despite recent profitability declines. Revenue continues to grow with management projecting $6.4–$6.7 billion for the year, while EBITDA and cash flow are expected to fall short of prior results. Professional fees pressured margins, but management expects this cost trend to moderate in the second half, signaling potential stabilization.

Company

About Ardent Health, Inc.

Ardent Health, Inc. is a healthcare services company that owns and operates a network of hospitals, clinics, and other care facilities across the United States. The company provides both general and specialty medical services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency care. Its operations span inpatient and ambulatory settings, supported by acute care hospitals, rehabilitation hospitals, surgical hospitals, ambulatory surgery centers, urgent care centers, free-standing emergency departments, diagnostic imaging centers, primary care clinics, specialty clinics, and telehealth services. Ardent Health, Inc. serves patients in growing mid-sized urban communities and works through a broad system of affiliated providers and subsidiaries to deliver integrated care across multiple settings. The company is based in Brentwood, Tennessee, and operates as a significant participant in the U.S. healthcare delivery market.

CEO Mr. David Caspers · 19,500 employees · United States · https://www.ardenthealth.com